Viola Allaj
Pfizer (United States)(US)
Publications by Year
Research Areas
Lung Cancer Research Studies, Cancer Mechanisms and Therapy, Neuroendocrine Tumor Research Advances, Cancer Immunotherapy and Biomarkers, Cancer Research and Treatments
Most-Cited Works
- → Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis(2017)647 cited
- → The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution(2020)574 cited
- → Regenerative lineages and immune-mediated pruning in lung cancer metastasis(2020)478 cited
- → Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer(2021)408 cited
- → Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity(2021)165 cited
- → Peptide-based PET quantifies target engagement of PD-L1 therapeutics(2018)135 cited
- → Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade(2023)130 cited
- → WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC(2022)127 cited
- → Targeting Lysine-Specific Demethylase 1 Rescues Major Histocompatibility Complex Class I Antigen Presentation and Overcomes Programmed Death-Ligand 1 Blockade Resistance in SCLC(2022)120 cited
- → Noninvasive Interrogation of DLL3 Expression in Metastatic Small Cell Lung Cancer(2017)116 cited